Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
0.3355
-0.0352 (-9.50%)
At close: Jul 17, 2026, 4:00 PM EDT
0.3580
+0.0225 (6.71%)
After-hours: Jul 17, 2026, 7:10 PM EDT
Trinity Biotech Market Cap
Trinity Biotech has a market cap or net worth of $6.79 million as of July 17, 2026. Its market cap has decreased by -50.87% in one year.
Market Cap
6.79M
Enterprise Value
139.64M
1-Year Change
-50.87%
Ranking
Category
Stock Price
$0.34
ChartMarket Cap Chart
Since October 9, 1997, Trinity Biotech's market cap has decreased from $44.82M to $6.79M, a decrease of -84.84%. That is a compound annual growth rate of -6.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 6.79M | -53.74% |
| Dec 31, 2025 | 14.69M | -4.25% |
| Dec 31, 2024 | 15.34M | -6.42% |
| Dec 29, 2023 | 16.39M | -56.55% |
| Dec 30, 2022 | 37.73M | 26.22% |
| Dec 31, 2021 | 29.89M | -62.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nexalin Technology | 9.73M |
| VolitionRx | 9.66M |
| Co-Diagnostics | 9.09M |
| HeartSciences | 8.73M |
| Phaos Technology Holdings (Cayman) Limited | 6.96M |
| enVVeno Medical | 6.85M |
| Sintx Technologies | 6.65M |
| Vivos Therapeutics | 5.74M |